Pseudomembranous Enterocolitis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for pseudomembranous enterocolitis. 23 active patents protecting 2 drugs from 2+ originators. First major cliff: 2027. Daily refresh.

2
Approved drugs
23
Active US patents
51/100
Avg vulnerability
$410M
Annual revenue covered

Originators in Pseudomembranous Enterocolitis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cubist Pharms Llc 18 patents ANI Pharmaceuticals 5 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating pseudomembranous enterocolitis. Each bar = one year. Y-axis scaled to peak year (10 patents).

10
27
6
28
2
34
5
35

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Dificid
FIDAXOMICIN
 Cubist Pharms Llc 18 63 $410M 2027-03-04
Vancocin
vancomycin
 ANI Pharmaceuticals 5 39 — 2035-11-06

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
7906489 Dificid method of use 85 2027-03-04
7906489 Dificid method of use 80 2027-03-04
8859510 Dificid method of use 80 2027-07-31
8859510 Dificid method of use 75 2027-07-31
7906489 Dificid other 75 2027-09-04
7906489 Dificid other 75 2027-09-04
7378508 Dificid other 75 2028-01-31
7378508 Dificid other 75 2028-01-31
8859510 Dificid other 75 2028-01-31
7863249 Dificid other 75 2028-01-31

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7378508 Dificid composition of matter 17 2027-07-31
7378508 Dificid composition of matter 22 2027-07-31
7863249 Dificid composition of matter 22 2027-07-31
10849956 Vancocin formulation 25 2035-11-06
11000567 Vancocin formulation 25 2035-11-06
9808530 Dificid formulation 42 2034-05-28
10039804 Vancocin method of use 45 2035-11-06
10188697 Vancocin method of use 45 2035-11-06
11517609 Vancocin method of use 53 2035-11-06
7863249 Dificid formulation 55 2027-07-31

Related